CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Sapropterin dihydrochloride

Last Updated: July 8, 2010
Result type: Reports
Project Number: S0205
Product Line: Common Drug Review

Generic Name: Sapropterin dihydrochloride

Brand Name: Kuvan

Manufacturer: BioMarin Pharmaceutical Canada Inc.

Indications: Phenylketonuria (PKU).

Submission Type: New

Project Status: Complete

Date Recommendation Issued: January 26, 2011

Recommendation Type: Do not list